Revision total hip arthroplasty in Jehovah's Witnesses.

  title={Revision total hip arthroplasty in Jehovah's Witnesses.},
  author={Steven F. Harwin and Robert Pivec and Aaron J. Johnson and Qais Naziri and Michael A Mont},
  volume={35 8},
  • S. Harwin, R. Pivec, Michael A Mont
  • Published 1 August 2012
  • Medicine
  • Orthopedics
Revision total hip arthroplasty (THA) is associated with greater blood loss than primary THA. Jehovah's Witnesses will not accept transfusions of blood or blood products and are thus at an increased risk for complications due to perioperative anemia. The purpose of this study was to report the clinical outcomes, radiographic outcomes, morbidity, and mortality of Jehovah's Witnesses who were medically optimized and underwent revision THA. Databases from 2 institutions were reviewed to identify… 

Figures and Tables from this paper

Blood management strategies in primary and revision total knee arthroplasty for Jehovah's Witness patients.
An overview of various potential preoperative, intraoperative, and postoperative blood management measures that may be used for the care of Jehovah's Witnesses who undergo knee arthroplasty procedures is provided.
Bloodless surgery by a regional intraarterial tourniquet during primary and revision THA.
Temporary internal tourniquets used as an adjuvant to surgery significantly reduce intraoperative blood loss during primary and revision THA and showed a significant reduction in hemoglobin immediately postoperatively compared with preoperative values.
A protocol avoiding allogeneic transfusion in joint arthroplasties
In patients who do not want allogeneic transfusions, the protocol developed is a safe alternative to perform joint arthroplasties and could be done without transfusion using this protocol in most of the patients.
What (if any) Special Factors Should Come into Preoperative Assessment of Patients for Bloodless Surgery
The field of bloodless surgery emerged in the 1960s when cardiac surgeons in Texas developed a ‘bloodless prime’ for cardiopulmonary bypass machines, enabling major cardiac surgery in patients excluded from such surgeries for reasons related to transfusion.
Two-stage surgery on pregnant woman with a giant cell tumor of bone who refused blood transfusion: A case report.
How do we treat life‐threatening anemia in a Jehovah's Witness patient?
A protocol‐based algorithm to the management of life‐threatening anemia in JW patients is described and review time to anemia reversal and patient outcomes using this approach are described.
Risk‐adjusted clinical outcomes in patients enrolled in a bloodless program
Although clinical outcomes have been reported for patients who do not accept allogeneic blood transfusion (ABT), many previous studies lack a control group, fail to use risk adjustment, and focus
Revision Total Hip Arthroplasty in Jehovah’s Witnesses at a Public Hospital: Practical Recommendations for a Low-Resource Setting
It is believed that the extrapolation of these crucial principles to the broader category of primary arthroplasty in the general population can be used to reduce the rate of blood transfusion, increase access to surgery, and improve outcomes.


Primary and revision total hip replacement in patients who are Jehovah's Witnesses.
The authors herein review their past and current experiences in the perioperative blood management of this patient population in an attempt to address the need for careful delineation and specific treatment guidelines.
Total hip arthroplasty in Jehovah's Witnesses without blood transfusion.
One hundred patients who were Jehovah's Witnesses underwent total hip replacement without transfusion, of which eighty-nine procedures were performed under hypotensive anesthesia, with a significant reduction in blood loss.
Mortality, morbidity, and 1-year outcomes of primary elective total hip arthroplasty.
Patients and surgeons in the United Kingdom should have access to this information when making a decision about THA, and patients and surgeons should be aware of the risks of adverse outcomes.
Total hip replacement in Jehovah's Witnesses under spinal anesthesia without transfusion.
Patients who were Jehovah's Witnesses underwent 107 total hip replacements without transfusion and sustained an average intraoperative blood loss of 300 mL, which was a significant reduction compared with that in controlled groups of patients reported by other authors.
Aprotinin Decreases Blood Loss in Patients Undergoing Revision or Bilateral Total Hip Arthroplasty
It is questionable whether the slight reduction in blood loss justifies routine use of this expensive drug, despite two recent studies showing decreased blood loss in patients given aprotinin undergoing primary hip replacement surgery.
Early postoperative mortality following total hip arthroplasty in a community setting: a single surgeon experience.
This experience of a single surgeon with a high volume community practice performing both primary and revision total hip arthroplasty, documents a low but significant incidence of postoperative death in the first 3 months of surgery.
Effects of Tranexamic Acid on Blood Loss during Total Hip Arthroplasty
A single dose of intravenous TA given 10 minutes prior to THA is a cost-effective and safe means of minimising blood loss and reduction in haemoglobin concentrations as well as the need for allogenic blood transfusion, without increasing the risk of thromboembolic events.
Prospective randomized evaluation of the need for blood transfusion during primary total hip arthroplasty with use of a bipolar sealer.
There were no significant differences between the treatment and control groups in terms of the need for blood transfusions or overall blood loss, and this bipolar sealing device was discontinued in uncomplicated primary total hip arthroplasty patients at this institution.
Intraoperative red blood-cell salvage in revision hip surgery. A case-matched study.
The first study in which the use of intraoperative red blood-cell salvage in revision hip arthroplasty was evaluated by matching patients on the basis of age, sex, and operative variables significantly lowered the allogeneic transfusion requirement.
Antifibrinolytics in Major Orthopaedic Surgery
  • J. Eubanks
  • Medicine
    The Journal of the American Academy of Orthopaedic Surgeons
  • 2010
Large meta‐analyses suggest that antifibrinolytics can be safely and efficaciously employed to decrease perioperative blood loss and transfusion requirements.